NDC 44567-503-01 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 44567-503
- Requested NDC
- 44567-503-01
- Package NDCs from labels
- 44567-503-01, 44567-503-10
- Manufacturer
- WG Critical Care, LLC
- Effective date
- 2024-03-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levetiracetam - WG Critical Care, LLC | WG Critical Care, LLC | 2024-03-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 44567-503-01 | Levetiracetam | 100 mL in 1 BAG | INJECTION | 100 | 6 | |
| 44567-503-10 | Levetiracetam | 10 in 1 CARTON | INJECTION | 10 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 44567-503-01 | ML - Milliliter | 44567-503 | 350017f4-5725-4c4d-95d6-02e9bd149200 | 1 | 2022-07-06 |
| 44567-503-10 | ML - Milliliter | 44567-503 | c1e451d3-1740-4d30-929f-2c1c3443a099 | 1 | 2022-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Levetiracetam Extended-Release | LEVETIRACETAM | Golden State Medical Supply, Inc. | 5dde1889-a217-4493-9a71-9fd39ed04630 | 2025-11-24 | Warnings, Adverse reactions | 44YRR34555 |
| Natural Eyes Floaters Relief | CHELIDONIUM, EUPHRASIA, KALI SULPH, NATRUM MURIATICUM, PHOSPHORUS, PHYSOSTIGMA, SEPIA, SILICEA | TRP Company | 445dc831-195e-4b25-e063-6294a90a6efd | 2025-11-24 | Warnings | 451W47IQ8X |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | 6e31e766-6504-4f20-8831-1953363cace0 | 2025-11-21 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Hp Halden Pharma AS | 1d9abcce-8ef7-422b-bf4b-5835bf4dbb34 | 2025-11-21 | Warnings, Adverse reactions | 1193362 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Hp Halden Pharma AS | 6951de41-4a16-4cca-8039-44fc81407081 | 2025-11-21 | Warnings, Adverse reactions | 1193358 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Hp Halden Pharma AS | 35bb1e5f-d5cd-4e7f-a056-48c0cf9ebd76 | 2025-11-21 | Warnings, Adverse reactions | 1193360 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | 01aef7f7-6092-4e39-8451-dc02d8db9254 | 2025-11-21 | Warnings, Adverse reactions | 44YRR34555 |
| LEVETIRACETAM | LEVETIRACETAM | Baxter Healthcare Corporation | 8e381590-1147-46f3-9cbd-dc9716013444 | 2025-11-20 | Warnings, Adverse reactions | 44YRR34555 |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 059QF0KO0R |
| Vital Female Sexual Energy | AGNUS CASTUS, ARNICA MONTANA, AVENA SATIVA, CAULOPHYLLUM THALICTROIDES, CINCHONA OFFICINALIS, DAMIANA, HYPOPHYSIS SUIS, L-ARGININE, NATRUM MURIATICUM, ONOSMODIUM VIRGINIANUM, OOPHORINUM SUIS, PHOSPHORICUM ACIDUM, SEPIA, THUJA OCCIDENTALIS | Liddell Laboratories, Inc. | 1ca43c82-62b0-4191-81a4-27f7f94109dd | 2025-11-20 | Warnings | 451W47IQ8X |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | 58ed7049-44c6-4f97-9174-c0e1504586a6 | 2025-11-19 | Warnings, Adverse reactions | 44YRR34555 |
| Sodium Chloride | SODIUM CHLORIDE | Walgreen Company | d112a344-33cc-41d3-bae6-492631ebdba7 | 2025-11-19 | Warnings | 451W47IQ8X |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | 5eb7bea5-c95f-4a38-a5bb-c20d1549c797 | 2025-11-19 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | bc12f0b0-e05c-48e4-ad08-0ff14a818a64 | 2025-11-19 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Coupler LLC | 43df4156-0958-e496-e063-6294a90a5329 | 2025-11-18 | Warnings, Adverse reactions | 44YRR34555 |
| Sodium chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | ce0c8c6f-734a-400f-9b60-a3b1e263f25f | 2025-11-18 | Warnings, Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | b9597cd5-5745-494a-bd72-93071ed221da | 2025-11-18 | Warnings, Adverse reactions | 44YRR34555 |
| Sodium Chloride | SODIUM CHLORIDE TABLETS | Kesin Pharma Corporation | 2f107592-10c5-ef3b-e063-6394a90a7c0a | 2025-11-17 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.